![Inflammation, Pravastatin, and the Risk of Coronary Events After Myocardial Infarction in Patients With Average Cholesterol Levels | Circulation Inflammation, Pravastatin, and the Risk of Coronary Events After Myocardial Infarction in Patients With Average Cholesterol Levels | Circulation](https://www.ahajournals.org/cms/asset/f066c0ff-5870-4f7a-9656-effb60175acd/hc3581807002.jpeg)
Inflammation, Pravastatin, and the Risk of Coronary Events After Myocardial Infarction in Patients With Average Cholesterol Levels | Circulation
![Relationship Between Plasma LDL Concentrations During Treatment With Pravastatin and Recurrent Coronary Events in the Cholesterol and Recurrent Events Trial | Circulation Relationship Between Plasma LDL Concentrations During Treatment With Pravastatin and Recurrent Coronary Events in the Cholesterol and Recurrent Events Trial | Circulation](https://www.ahajournals.org/cms/asset/b242ddbc-b0e7-4ffe-bb5b-d1fa73be1953/hc1581448001.jpeg)
Relationship Between Plasma LDL Concentrations During Treatment With Pravastatin and Recurrent Coronary Events in the Cholesterol and Recurrent Events Trial | Circulation
![Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events | Circulation Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events | Circulation](https://www.ahajournals.org/cms/asset/6338b538-05fc-4500-a142-3cd2aab00bca/2494fig01.jpeg)